Home
Service
Binder Discovery
Application-Specific Nanobody Discovery
Nanobody Expression & Production
Nanobody Engineering
Platforms
Yeast Display Platform
Phage Display Platform
Resources
Blog
Publications
Contact Us
English
Home
Service
Binder Discovery
Nanobody Discovery
Yeast Display VHH Discovery Service
Immunogen Design & Production
Premade Library Screening
Phage Display Nanobody Discovery Service
Animal Immunization
Peptide Discovery
Yeast Display Peptide Library Screening
Application-Specific Nanobody Discovery
Nanobody Discovery for ADC
Nanobody Discovery for Membrane Targets
Nanobody Discovery for Cell Therapy
TCR-Mimic Nanobody Discovery
Nanobody Expression & Production
Nanobody Expression & Production
Nanobody Engineering
Antibody Affinity Maturation Service
Nanobody Humanization Service
Platforms
Yeast Display Platform
Phage Display Platform
Resources
Blog
Publications
Contact Us
Binder Discovery
Nanobody Discovery
Yeast Display VHH Discovery Service
Immunogen Design & Production
Premade Library Screening
Phage Display Nanobody Discovery Service
Animal Immunization
Peptide Discovery
Yeast Display Peptide Library Screening
Application-Specific Nanobody Discovery
Nanobody Discovery for ADC
Nanobody Discovery for Membrane Targets
Nanobody Discovery for Cell Therapy
TCR-Mimic Nanobody Discovery
Nanobody Expression & Production
Nanobody Expression & Production
Nanobody Engineering
Antibody Affinity Maturation Service
Nanobody Humanization Service
Home
Resources
Publications
Publications
NBbiolab is a specialized company focused on the early discovery of single domain antibodies, offering professional expertise and high-quality custom services to support partners in their drug discovery efforts.
Publications
Structural basis of the substrate recognition and inhibition mechanism of Plasmodium falciparum nucleoside transporter PfENT1
Chen Wang, Leiye Yu, Jiying Zhang, Yanxia Zhou, Bo Sun, Qingjie Xiao, Minhua Zhang, Huayi Liu, Jinhong Li, Jialu Li, Yunzi Luo, Jie Xu, Zhong Lian, Jingwen Lin, Xiang Wang, Peng Zhang, Li Guo, Ruobing Ren & Dong Deng
2023
Nature Communications
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses.
Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Yuqing Lei, Lin Cheng, Qingtai Liang, Junxian Hong, Yiling Yang, Jing Chen, Yi Hao Wong, Jing Wei, Sisi Shan, Senyan Zhang, Jiwan Ge, Ruoke Wang, Jay Zengjun Dong, Yuxing Chen, Xuanling Shi, Qi …
2022
Nature Communications
99mTc-CD3813: A Nanobody-Based Single Photon Emission Computed Tomography Radiotracer with Clinical Potential for Myeloma Imaging and Evaluation of CD38 Expression
Linqing Shi, Bo Chen, Tianyu Liu, Liqiang Li , Biao Hu, Chenzhen Li, Bing Jia, Fan Wang
2022
Molecular Pharmaceutics
Pilot study of a novel nanobody 68 Ga-NODAGA-SNA006 for instant PET imaging of CD8+ T cells
Yan Wang, Chao Wang, Minzhou Huang, Songbing Qin, Jun Zhao, Shibiao Sang, Meng Zheng, Yicong Bian, Chenrong Huang, Hua Zhang, Lingchuan Guo, Jiwei Jiang, Chun Xu, Na Dai, Yushuang Zheng, Jiajun Han, Min Yang, Tao Xu, Liyan Miao
2022
EJNMMI
A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding
Jing Yang, Sheng Lin, Honglu Sun, Zimin Chen, Fanli Yang, Xi Lin, Liyan Guo, Lingling Wang, Ao Wen, Xindan Zhang, Yushan Dai, Bin He, Yu Cao, Haohao Dong, Xianbo Liu, Bo Chen, Jian Li, Qi Zhao, Guangwen Lu
2022
Frontiers in Immunology
Development of a nanobody tagged with streptavidin-binding peptide and its application in a Luminex fluoroimmunoassay for alpha fetal protein in serum
Qi Chen, Danyang Sun, Hua Pei, Benchao Su, Kunlu Bao, Hongmei Cao, Chenghui Zhang, Bruce D Hammock, Xing Liu
2020
RSC Advances